Review challenges use of home oxygen for moderate hypoxaemia
Pooled data from high-quality studies suggest guidelines may need to be brought up to date, leading physicians say
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/home-oxygen-senior-woman-iStock-1277185134-1.jpg)
Home oxygen provides no survival benefit in patients with COPD and moderate hypoxaemia, nor does it reduce the rate of hospitalisations, according to findings from a potentially practice-changing study.
International researchers say there is little evidence to support the widespread use of long-term oxygen therapy (LTOT) or nocturnal oxygen therapy in this patient population.